Long-term follow-up of HIV-1 multi-drug-resistant treatment-experienced participants treated with etravirine, raltegravir and boosted darunavir: towards drug-reduced regimen? ANRS CO3 Aquitaine Cohort 2007–2018.

Autor: Nyamankolly, Elsa1 (AUTHOR) nyamankollye@ch-dax.fr, Bellecave, Pantxika2 (AUTHOR), Wittkop, Linda3,4 (AUTHOR), Le Marec, Fabien3 (AUTHOR), Duffau, Pierre5,6 (AUTHOR), Lazaro, Estibaliz5,7 (AUTHOR), Vareil, Marc-Olivier5,8 (AUTHOR), Tumiotto, Camille2,9 (AUTHOR), Hessamfar, Mojgan3,5,10 (AUTHOR), Cazanave, Charles1 (AUTHOR), Perrier, Adélaïde3 (AUTHOR), Leleux, Olivier3 (AUTHOR), Bonnet, Fabrice1,3,5,10 (AUTHOR), Neau, Didier1,5 (AUTHOR)
Zdroj: International Journal of Antimicrobial Agents. Jan2023, Vol. 61 Issue 1, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: